对第三代双能CT和IVUS进行对比分析,用于检测静脉静脉缩
Mohey E A Eldeeb1, Mohamed A Mostafa2, Tarek A Nagiub1
1Department of Cardiovascular Medicine, Faculty of Medicine, Zagazig University, Zagazig, 44519, Egypt.
BMC cardiovascular disorders
|August 20, 2025
概括
第三代双源双能CT (DSDECT) 准确评估静脉静脉缩 (ISDR),匹配侵入性方法. 它的高负预测值可能可以避免在稳定患者具有专利支架的侵入性血管造影.
科学领域:
- 心血管成像 - 心血管成像
- 电脑图像扫描血管造影 CT血管造影
- 干预性心脏病学 干预性心脏病学
背景情况:
- 静脉支架直径复缩 (ISDR) 是冠状动脉支架后的一个关键并发症.
- 之前的评估依赖于64片多元检测器计算机断层扫描冠状动脉血管学 (MDCT-CA) 与侵入性冠状动脉血管学 (ICA).
- 第三代双源双能CT (DSDECT) 提供了用于评估冠状动脉的先进成像功能.
研究的目的:
- 为了将DSDECT的诊断准确性与ICA进行比较,用于评估ISDR.
- 评估DSDECT在识别静脉静脉复缩 (ISDR) 的性能,使用静脉内超声波 (IVUS) 作为参考标准.
- 评估DSDECT在潜在减少侵入性手术的必要性方面的实用性.
主要方法:
- 95名患有110个冠状动脉支架的患者在24小时内接受了DSDECT,ICA和IVUS.
- DSDECT和ICA的性能指标 (灵敏度,特异性,PPV,NPV) 与IVUS进行了比较.
- 在IVUS上,静脉支架区域缩 (ISAR) 和最小光面积 (MLA) ≤4.0mm2作为ISDR的参考标准.
主要成果:
- 与IVUS相比,DSDECT在检测ISDR方面表现出高灵敏度 (100%),特异性 (92.4%) 和准确性 (96.1%).
- 在使用4.0mm2的IVUS MLA时识别ISDR时,没有发现DSDECT和ICA之间的显著差异.
- DSDECT在评估小于3毫米的支架方面存在局限性,需要仔细选择患者.
结论:
- 第三代DSDECT的性能与ICA和IVUS在评估支架发明性方面具有相似的性能.
- DSDECT为评估ISDR提供了非侵入性的,具有成本效益和用户友好的优势.
- DSDECT的100%NPV可以可靠地排除ISDR,可能避免在选择的稳定患者中进行侵入性血管造影.
相关概念视频
Imaging Studies for Cardiovascular System V: CT
66
Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
66
Acute Coronary Syndrome III: Diagnostic Studies
23
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
23
Imaging Studies for Cardiovascular System II:Types of Echocardiography
395
Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for...
395
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
34
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
34
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
119
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
119


